Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
This systematic review and meta-analysis on randomized controlled trials (RCTs) evaluated the impact of astaxanthin (AST) supplementation on blood pressure in adults. We conducted a comprehensive search using different electronic databases. Ten RCTs with 493 participants that reported the effect of...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f137e5c75ab441a595840832dfc396c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f137e5c75ab441a595840832dfc396c0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f137e5c75ab441a595840832dfc396c02021-11-24T04:27:35ZImpact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials1756-464610.1016/j.jff.2021.104860https://doaj.org/article/f137e5c75ab441a595840832dfc396c02021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1756464621005090https://doaj.org/toc/1756-4646This systematic review and meta-analysis on randomized controlled trials (RCTs) evaluated the impact of astaxanthin (AST) supplementation on blood pressure in adults. We conducted a comprehensive search using different electronic databases. Ten RCTs with 493 participants that reported the effect of AST supplementation on blood pressure in adults were included. AST supplementation led to a marginally decline in diastolic blood pressure (DBP) (mean difference (MD) = −1.21; 95 %CI: −2.51, 0.09), but not systolic blood pressure. In patients, AST supplementation reduced DBP by 2.77 mmHg (95 %CI: −4.34, −1.19). Also, assigning ≥ 12 mg of AST to adults resulted in a slight decrease in DBP (MD = −0.89; 95 %CI: −1.82, 0.04). AST supplementation significantly reduced DBP by 2.27 mmHg in participants from Asian countries (95 %CI: −3.71, −0.83). This meta-analysis of RCTs disclosed that AST supplementation could reduce DBP, especially with a dose of ≥ 12 mg/d supplementation, in patient individuals and in participants from Asian countries.Elahe MokhtariSahar RafieiNafiseh Shokri-MashhadiParvane SaneeiElsevierarticleAstaxanthinSystolic blood pressureDiastolic blood pressureRandomized controlled trialsMeta-analysisNutrition. Foods and food supplyTX341-641ENJournal of Functional Foods, Vol 87, Iss , Pp 104860- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Astaxanthin Systolic blood pressure Diastolic blood pressure Randomized controlled trials Meta-analysis Nutrition. Foods and food supply TX341-641 |
spellingShingle |
Astaxanthin Systolic blood pressure Diastolic blood pressure Randomized controlled trials Meta-analysis Nutrition. Foods and food supply TX341-641 Elahe Mokhtari Sahar Rafiei Nafiseh Shokri-Mashhadi Parvane Saneei Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials |
description |
This systematic review and meta-analysis on randomized controlled trials (RCTs) evaluated the impact of astaxanthin (AST) supplementation on blood pressure in adults. We conducted a comprehensive search using different electronic databases. Ten RCTs with 493 participants that reported the effect of AST supplementation on blood pressure in adults were included. AST supplementation led to a marginally decline in diastolic blood pressure (DBP) (mean difference (MD) = −1.21; 95 %CI: −2.51, 0.09), but not systolic blood pressure. In patients, AST supplementation reduced DBP by 2.77 mmHg (95 %CI: −4.34, −1.19). Also, assigning ≥ 12 mg of AST to adults resulted in a slight decrease in DBP (MD = −0.89; 95 %CI: −1.82, 0.04). AST supplementation significantly reduced DBP by 2.27 mmHg in participants from Asian countries (95 %CI: −3.71, −0.83). This meta-analysis of RCTs disclosed that AST supplementation could reduce DBP, especially with a dose of ≥ 12 mg/d supplementation, in patient individuals and in participants from Asian countries. |
format |
article |
author |
Elahe Mokhtari Sahar Rafiei Nafiseh Shokri-Mashhadi Parvane Saneei |
author_facet |
Elahe Mokhtari Sahar Rafiei Nafiseh Shokri-Mashhadi Parvane Saneei |
author_sort |
Elahe Mokhtari |
title |
Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials |
title_short |
Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials |
title_full |
Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials |
title_fullStr |
Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials |
title_full_unstemmed |
Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials |
title_sort |
impact of astaxanthin supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/f137e5c75ab441a595840832dfc396c0 |
work_keys_str_mv |
AT elahemokhtari impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT saharrafiei impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT nafisehshokrimashhadi impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT parvanesaneei impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials |
_version_ |
1718416011991973888 |